SALV Salvarx Group Plc

TIDMSALV

RNS Number : 3447Z

SalvaRx Group plc

09 January 2020

9 January 2020

SalvaRx Group plc

("SalvaRx" or the "Company")

Cancellation of trading on AIM

Further to the Company's announcement of 20 December 2019, SalvaRx confirms that the cancellation of the admission to trading of the Company's ordinary shares on AIM will take effect from 7.00 a.m. on 10 January 2020.

The Board anticipates making a further announcement about a potential acquisition shortly which will, should this transaction proceed, involve a reverse takeover by the Company and re-listing of the Company's ordinary shares.

Enquiries

 
 SalvaRx Group plc                             Tel: +44 (0) 01624 
  Denham Eke                                         639396 
 SP Angel Corporate Finance LLP                 Tel: +44 (0) 20 
  Nominated Adviser and Broker                      3470 0470 
  Matthew Johnson / Caroline Rowe (Corporate 
  Finance) 
  Abigail Wayne (Corporate Broking) 
 Peterhouse Corporate Finance Limited             Tel: +44 (0) 20 
  Joint Broker                                          7469 0932 
  Lucy Williams / Duncan Vasey 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCUPUQGGUPUGCB

(END) Dow Jones Newswires

January 09, 2020 09:30 ET (14:30 GMT)

Salvarx (LSE:SALV)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025

Salvarx (LSE:SALV)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025